NeoGenomics, Inc. (NEO) — Analysis Summary
NeoGenomics, Inc. (NEO) has a market cap of $1.37B with year-over-year revenue growth of +10.1%. Net margin stands at -14.9%. The stock trades at a P/E ratio of -13.8.
Key Takeaways
- Revenue changed +10.1% year-over-year
- Net margin of -14.9%
- P/E ratio of -13.8
Compared to other companies in the SERVICES-TESTING LABORATORIES sector, NEO posted revenue growth of +10.1% and trades at a P/E of -13.8.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.